Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer

Bo Mi Ku(Samsung Medical Center), Myung‐Ju Ahn(Samsung Medical Center)
Investigational New Drugs
May 24, 2019
Cited by 50


Related Papers